Over the past year, ARKW is up 161% over the past five years, it’s up 769%, making it the best performer in ARK’s suite over both those time periods. The top holdings of ARKW are currently Tesla, Square, the Grayscale Bitcoin Trust, Teladoc and Roku, with position sizes ranging from 3.9% to 10%. These stocks tend to touch on areas like cloud computing, cybersecurity, e-commerce, big data, AI and blockchain. With a 0.2% loss, the ETF has completely wiped out what was as much as a 28% gain in February.ĪRKW’s focus is on the companies you might think of when you think of technology: software firms, hardware firms, social media firms, etc. Just like the already-mentioned ARKK and ARKG, ARKW is down this year. The picture is a bit different over the past nine sessions in that period, the fund registered outflows in all but one day, for net redemptions of $719 million in the period. This fund holds 8.3 billion in assets under management and year-to-date inflows of $2.4 billion (incidentally, every one of ARK’s seven ETFs has seen net inflows this year). The third-largest of the ARK ETFs is the ARK Next Generation Internet ETF (ARKW). TDOC, with its 7.3% weighting, is followed by Regeneron, Exact Sciences, Pacific Biosciences and Novartis, each with weightings of more than 4%.Įven after its recent plunge, ARKG is still up 154% over the past year, and 423% over the past five years. For example, the fund’s top holding is currently the telemedicine company Teladoc. The vast majority of ARKG’s portfolio consists of drugmakers-biotech and pharma companies-but not all of it. Companies targeted include those related to gene editing, bioinformatics, precision medicine, stem cells, agricultural biology and more. At its high in February, ARKG was up more than 20%.ĪRKG is a health care fund at its core, but one with a bias toward genomics-related stocks. The fund is down 8.7% year-to-date, making it this year’s worst-performing ETF in ARK’s suite. That said, the fund has hit a rough patch recently, registering outflows in seven of the past nine sessions for total net redemptions of $1.1 billion in the period. The ARK Genomic Revolution ETF (ARKG) has been the most popular among those funds, with assets totaling $10 billion, including net inflows of $3.2 billion this year. Its six other exchange-traded funds are more targeted, offering investors potent exposure to the company’s favored technological themes. The aforementioned ARKK is ARK Invest’s most diversified ETF. At the same time, assets under management in the ETF have grown tenfold in just the past 11 months. It’s up 149% over the past year, and 586% over the past five years. Recent losses notwithstanding, ARKK’s focus on disruptive tech has served it extremely well. It hits on themes like AI, autonomous vehicles, fintech, DNA sequencing, robotics and 3D printing.Ĭurrent top holdings include Tesla, Square, Roku, Teladoc and Baidu, with weightings ranging from 3.6% and 10%. That includes more than $700 million of inflows since the fund peaked last month-though the pace of new buying has slowed from the torrid pace of earlier this year.ĪRKK’s portfolio contains a sampling of stocks from each of the issuer’s other more-focused funds. Far from it year-to-date net inflows for ARKK total $6 billion. Yet even as the ETF has tumbled, investors haven’t headed for the hills. That’s quite the turnaround from when the fund was up 25.8% in mid-February. The flagship ARKK, a $22.9 billion fund that holds a cross section of high-growth stocks from multiple sectors, is the second-worst performer of the bunch, with a year-to-date loss of 6%.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |